期刊文献+

合并前列腺炎症的良性前列腺增生组织中Integrinα_2β_1/CD133表达及其意义 被引量:8

Expressions of Integrinα_2β_1 and CD133 in benign prostatic hyperplasia complicated by prostatitis and their significance
下载PDF
导出
摘要 目的:探讨合并前列腺炎症的良性前列腺增生(BPH)组织中Integrinα2β1/CD133表达及其意义。方法:收集56例行经膀胱前列腺摘除手术的BPH患者的前列腺标本,常规HE染色后观察其合并炎症情况,其中单纯BPH(24例)为A组,合并前列腺炎症的BPH(32例)为B组。采用免疫组化SP法及Western印迹法检测Integrinα2β1/CD133在两组前列腺组织中表达差异。Image-ProPlus 6.0图像分析软件对结果进行分析。结果:免疫组化Mattern积分结果显示:两组中Integrinα2β1/CD133表达有显著差异(P<0.05)。Western免疫印迹显示:B组Integrinα2β1平均相对光密度值高于A组[(0.29±0.18)vs(0.04±0.03)],P<0.05;B组CD133平均相对光密度值高于A组[(0.08±0.07)vs(0.002 0±0.001 8)],P<0.05。提示B组中Integrinα2β1/CD133表达较A组显著升高。结论:炎症可以促进BPH组织中Integrinα2β1/CD133蛋白表达表达。 Objective: To study the expressions of Integrinα2β1 and CD133 in benign prostatic hyperplasia(BPH) complicated by prostatitis and their significance.Methods: Specimens were obtained from 56 BPH patients undergoing transvesical prostatectomy.Paraffin sections of the specimens were subjected to HE staining for pathological examination of inflammatory changes under the light microscope.Twenty-four patients with simple BPH were included in Group A,and the other 32 with BPH complicated with prostatitis in Group B.The expressions of Integrinα2β1 and CD133 in the prostatic tissues of the two groups were determined by immunohistochemistry,Western blotting and IPP6.0 image analysis software.Results: The expressions of Integrinα2β1 and CD133 were significantly higher in Group B than in A(P 0.05),and so were the mean relative value of the optical density of Integrinα2β1(0.29 ± 0.18 vs 0.04 ± 0.03) and that of CD133(0.08 ± 0.07 vs 0.002 0 ± 0.001 8)(P 0.05).Conclusion: Inflammation can up-regulate the expressions of Integrinα2β1 and CD133 in BPH tissue.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2011年第10期909-912,共4页 National Journal of Andrology
关键词 良性前列腺增生 前列腺炎症 Integrinα2β1/CD133 prostatitis benign prostatic hyperplasia Integrinα2β1/CD133
  • 相关文献

参考文献8

  • 1常德贵,李广森,张培海,吴天浪,梅雪峰,曹军,高坪.良性前列腺增生合并慢性前列腺炎的临床特点分析[J].中华男科学杂志,2010,16(9):830-833. 被引量:13
  • 2Albelda SM, Buck CA. Integrin and other cell adhesion molicules. FASEB J, 1990, 4(11): 2868-2880.
  • 3Collins AT, Habib FK, Maitland NJ, et al. Identification and isolation of human prostate epithelial stem cells based on α2β1- integrin expression. J Cell Sci, 2001, 114(Pt 21): 3865-3872.
  • 4Schalken JA, van Leenders G. Cellular and molecular biology of the prostate : Stem cell biology. Urology, 2003,62 (5 suppl 1 ) : 11-20.
  • 5Begley LA, Kasina S, Mac Donald J, et al. The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine, 2008, 43(2) : 194-199.
  • 6Mattern J, Koanagi R, Volta M. Association of vascular endothe-lium growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung cancer. Br J Cancer, 1996, 73(7) : 931-934.
  • 7马跃,张唯力.良性前列腺增生合并慢性前列腺炎的研究进展[J].中华男科学杂志,2010,16(7):646-650. 被引量:39
  • 8贺大林.前列腺增生的病因学研究进展[J].临床外科杂志,2005,13(2):72-74. 被引量:11

二级参考文献35

  • 1夏同礼,邓方明,冯陶.血清前列腺特异性抗原增高的病理基础[J].中华医学杂志,1994,74(5):306-308. 被引量:22
  • 2张唯力,戴君勇,魏武然,王志刚,冉海涛.超声辐照微泡对大鼠前列腺增生组织通透性的影响[J].中国医学影像技术,2007,23(1):27-30. 被引量:5
  • 3Blumenfeld W, Tucci S, Narayan P. Incidental lymphecytic prostatitis. Selective involvement with nonmalignant glands. Am J Surg Pathol, 1992, 16(10) : 975-981.
  • 4Gerstenbluth RE, Seftel AD, MacLennan GT, et al. Distribution of chronic prostatitis in radical prostatectomy specimens with up- regulation of bcl-2 in areas of inflammation. J Urol, 2002, 167 (5) : 2267-2270.
  • 5Collins MM, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol, 2002, 167(3) : 1363-1366.
  • 6Delongchamps NB, de la Roza G, Chandan V, et al. Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer.'? J Urol, 2008, 179(5): 1736-1740.
  • 7Konig JE, Senge T, Allhoff EP, et al. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate, 2004, 58(2): 121-129.
  • 8Mishra VC, Allen DJ, Nicolaou C, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 2007, 100(2) : 327-331.
  • 9Steiner G, Gessl A, Kramer G, et al. Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia. J Urol, 1994, 15t(2) : 480-484.
  • 10Nickel JC. Prostatic inflammation in benign prostatic hyperplasia-- the third component? Can J Urol, 1994, 1(1) : 1-4.

共引文献55

同被引文献49

  • 1梁秀山.良性前列腺增生症的治疗现状[J].中国医药导报,2010,7(23):12-14. 被引量:17
  • 2刘玉强,徐祗顺,史本康,王传运.萘哌地尔片治疗良性前列腺增生症的临床研究[J].山东大学学报(医学版),2005,43(12):1170-1172. 被引量:4
  • 3霍盛龙.中西医结合治疗前列腺增生症疗效分析[J].中国医药导报,2007,4(08S):82-83. 被引量:1
  • 4那彦群,叶章群,孙光.中国泌尿外科痰病诊断治疗指南[M].北京:人民卫生出版社,2011:116-146.
  • 5Delongchamps NB, dela Roza G, Chandan V, et al. Evaluation of prostatitis in autopsied prostates-is chronic inflammation more associated with benign prostatic hyperplasia or cancer [ J ]. J Urol, 2008,179 (5) : 1736 - 1740.
  • 6Matsumoto S, Kawai Y, Oka M, et al. Bladder function in 1713-estradiol- induced nonbacterial prostatitis model in Wistar rat[ J ]. Int Urol Neph- rol,2013,45 (3) :749-754.
  • 7Thumbikat P, Shahrara S, Sobkoviak R, et al. Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory media- tors[J]. J Urol,2010,184(4) :1536-1542.
  • 8Kim HJ,Park JW,Cho YS,et al. Pathogenic role of HIF-lc~ in prostate hyperplasia in the presence of chronic inflammation [ J ]. Biochim Bio- phys Acta,2013,1832( 1 ) :183-194.
  • 9Collins MM, Meigs JB, Barry MJ, et al. Prevalence and cor- relates of prostatitis in the health professionals follow-up study cohort[ J]. J Uro1,2002,167 (3):1363 -1366.
  • 10Fibbi B, Penna G, Morelli A, et al. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia [ J ]. Int J Androl,2010,33 (3) :475 - 488.

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部